Fermentation optimization for the production of lovastatin by Aspergillus terreus: use of response surface methodology
- 3 September 2004
- journal article
- research article
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 79 (10) , 1119-1126
Abstract
A Box–Behnken experimental design was used to investigate the effects of five factors—ie oxygen content in the gas phase; concentrations of C, N and P; and fermentation time—on the concentrations of biomass and lovastatin produced in batch cultures of Aspergillus terreus. The values of the various factors in the experiment ranged widely, as follows: 20–80% (v/v) oxygen in the aeration gas; 8–48 g dm−3 C‐concentration; 0.2–0.6 g dm−3 N‐concentration; 0.5–2.5 g dm−3 phosphate‐concentration; and 7–11 days fermentation time. No previous work has used statistical analysis in documenting the interactions between oxygen supply and nutrient concentrations in lovastatin production. The Box–Behnken design identified the oxygen content in the gas phase as the principal factor influencing the production of lovastatin. Both a limitation and excess of oxygen reduced lovastatin titers. A medium containing 48 g dm−3 C supplied as lactose, 0.46 g dm−3 N supplied as soybean meal, and 0.79 g dm−3 phosphate supplied as KH2PO4, was shown to support high titers (∼230 mg dm−3) of lovastatin in a 7‐day fermentation in oxygen‐rich conditions (80% v/v oxygen in the aeration gas). Under these conditions, the culture medium had excess carbon but limiting amounts of nitrogen. The optimized fermentation conditions raised the lovastatin titer by four‐fold compared with the worst‐case scenario within the range of factors investigated. Copyright © 2004 Society of Chemical IndustryKeywords
This publication has 23 references indexed in Scilit:
- The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged culturesProcess Biochemistry, 2003
- Lovastatin Biosynthesis by Aspergillus terreus in a Chemically Defined MediumApplied and Environmental Microbiology, 2001
- Repeated fed-batch process for improving lovastatin productionProcess Biochemistry, 2000
- Experimental design for fermentation media development: Statistical design or global random search?Journal of Bioscience and Bioengineering, 2000
- Empirical models for oxygen mass transfer: a comparison between shake flask and lab-scale fermentor and application to manganiferous ore bioleachingProcess Biochemistry, 1998
- Biosynthesis of ML-236C and the hypocholesterolemic agents compactin by Penicillium aurantiogriseum and lovastatin by Aspergillus terreus: determination of the origin of carbon, hydrogen and oxygen atoms by 13C NMR spectrometry and observation of unusual labelling of acetate-derived oxygens by 18O2Journal of the Chemical Society, Perkin Transactions 1, 1996
- Lovastatin Induces Growth Inhibition and Apoptosis in Human Malignant Glioma CellsBiochemical and Biophysical Research Communications, 1994
- Revision of the biosynthetic origin of oxygens in mevinolin (lovastatin), a hypocholesterolemic drug from Aspergillus terreus MF 4845Journal of the American Chemical Society, 1994
- Lovastatin and Simvastatin - Inhibitors of HMG CoA Reductase and Cholesterol BiosynthesisCardiology, 1990
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976